三重多原发恶性肿瘤病例分析

doi:10.3969/j.issn.1000-8535.2023.01.006

广州医药 ›› 2023, Vol. 54 ›› Issue (1): 34-38.DOI: 10.3969/j.issn.1000-8535.2023.01.006

三重多原发恶性肿瘤病例分析

莫称龙, 赖海岸, 胡桂和, 莫泽珣, 黄晓梅, 侯乐, 魏树全

广州市第一人民医院呼吸与危重症医学科二区(广州 510180)

收稿日期:2022-03-04 出版日期:2023-01-20 发布日期:2023-02-07
通讯作者: 魏树全,E-mail:eyweishuquan@scut.edu.cn
基金资助:
广东省中医药局科研项目(20222176);广州市卫生健康科技项目(20222A010039);广东省研究生教育创新计划项目(2015QTLXXM23)

Analysis of triple multiple primary malignant neoplasms

MO Chenglong, LAI Hai'an, HU Guihe, MO Zexun, HUANG Xiaomei, HOU Le, WEI Shuquan

Departerment of Pulmonary and Critical Care Medicine(Area 2), Guangzhou First People's Hospital, Guangzhou 510180, China

Received:2022-03-04 Online:2023-01-20 Published:2023-02-07

摘要/Abstract

摘要： 目的探讨多原发恶性肿瘤(MPMN)的临床特点,提高该类型肿瘤的认识,为临床诊断及治疗提供一定的经验。方法分析2021年12月广州市第一人民医院呼吸与危重症学科二区收治的1例乳腺、甲状腺及肺三重多原发恶性肿瘤的临床特点及诊治经过,并结合相关文献进行回顾分析。结果该例首患乳腺导管内癌并予手术切除,9年后再同时患肺癌及甲状腺癌,最终确诊为三重多原发恶性肿瘤。结论通过对多原发恶性肿瘤的临床特点的分析研究,可一定程度提高临床医生对MPMN的认知以及早期临床鉴别的能力,亦为肿瘤患者早期诊断、早期治疗提供更好的时机,改善患者生活质量。

关键词: 多原发恶性肿瘤, 乳腺癌, 甲状腺癌, 肺癌, 手术治疗

Abstract: Objective To explore the clinical characteristics of multiple primary malignant neoplasms (MPMN), to improve the understanding of this type of tumors, and to provide some experience for clinical diagnosis and treatment. Methods The clinical characteristics, diagnosis and treatment of a case with triple MPMN of breast, thyroid and lung treated in the Respiratory and Critical Care Department (Area 2) of Guangzhou First People's Hospital in December 2021 were analyzed retrospectively. Results The breast intraductal carcinoma was the first tumor of that case and had been resected, and 9 years later, lung cancer and thyroid cancer occured at the same time, which were diagnosed as triple MPMN. Conclusions The analysis and study of the clinical characteristics of MPMN can improve the clinicians' cognition and the ability of early clinical differentiation, and provide a better opportunity for early diagnosis and early treatment of tumor patients, and improve their quality of life.

Key words: multiple primary malignant neoplasms, breast cancer, thyroid cancer, lung cancer, surgical treatment

莫称龙, 赖海岸, 胡桂和, 莫泽珣, 黄晓梅, 侯乐, 魏树全. 三重多原发恶性肿瘤病例分析[J]. 广州医药, 2023, 54(1): 34-38.

MO Chenglong, LAI Hai'an, HU Guihe, MO Zexun, HUANG Xiaomei, HOU Le, WEI Shuquan. Analysis of triple multiple primary malignant neoplasms[J]. Guangzhou Medical Journal, 2023, 54(1): 34-38.

参考文献

[1] YAMAUCHI H, TAKEI J. Management of hereditary breast and ovarian cancer[J]. Int J Clin Oncol,2018,23(1):45-51.
[2] SINGH J, THOTA N, SINGH S, et al. Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel:prevalence of BRCA1/2 and non-BRCA mutations[J]. Breast Cancer Res Treat,2018,170(1):189-196.
[3] WANG H, HOU J, ZHANG G, et al. Clinical characteristics and prognostic analysis of multiple primary malignant neoplasms in patients with lung cancer[J]. Cancer Gene Ther,2019,26(11-12),419-426.
[4] SIMEONOVSKI V, BRESHKOVSKA H, DUMA S, et al. Hydroxyurea associated cutaneous lesions: A case report[J]. Open Access Maced J Med Sci,2018,6(8):1458-1461.
[5] ZHAI C Y, CAI Y L, LOU F, et al. Multiple primary malignant tumors-A clinical analysis of 15,321 patients with malignancies at a single center in China[J]. J Cancer,2018,9(16):2795-2801.
[6] AL-HUSSEINI M J, MOHAMED H H, SAAD A M, et al. Risk and survival of chronic myeloid leukemia after breast cancer: A population-based study[J]. Curr Probl Cancer,2019,43(3):213-221.
[7] NEMES A, TODOR N, NAGY V. Clinicopathological characteristics of patients with multiple primary neoplasms-a retrospective analysis[J]. J BUON,2018,23(6):1846-1854.
[8] PAREKH J D, KUKRETY S, THANDRA A, et al. Multiple primary malignant neoplasms in an elderly patient[J]. Cureus,2018,10(3):2384.
[9] DUANMU Y Y, WANG R P. Professor Wang experience in the treatment of multiple primary cancer[J]. Guid J Tradit Chin Med Pharmacol,2018,24(9):53-54.
[10] 魏星, 刘向阳.同时性多原发肺腺癌31例临床分析与治疗体会[J]. 中国医刊,2017,52(5):86-90.
[11] 罗伟平, 何雩霏, 钟礼信, 等. 2008—2019年广州某综合医院肿瘤病例分析[J]. 广州医药, 2020, 51(4): 114-118.
[12] 宋诗平, 赵越, 王春玉, 等. 雌激素受体在甲状腺癌中作用的研究进展[J]. 第三军医大学学报,2017,29(5),489-494.
[13] 魏晓玲, 洪英极, 王林硕, 等. 潮汕地区原发性双侧乳腺癌癌灶间相关性分析[J]. 汕头大学医学院学报,2018,31(4):234-238.
[14] CHATURVEDI A K, ENGELS E A, GILBERT E S, et al. Second cancers among 104 760 survivors of cervical cancer: Evaluation of long-term risk[J]. J Natl Cancer Inst,2017,99(21):1634-1643.
[15] PAPPAS K, XU J, ZAIRIS S, et al. p53 maintains vaseline expression of multiple tumor suppressor genes[J]. Mol Cancer Res,2017,15(8):1051-1062.
[16] BERNSTEIN J L, WECARE Study Collaborative Group, CONCANNON P. ATM, radiation, and the risk of second primary breast cancer[J]. Int J Radiat Biol,2017,93(10):1121-1127.
[17] MAYADEV J, LIM J, DURBIN B, et al. Smoking decreases survival in locally advanced cervical cancer treated with radiation[J]. Am J Clin Oncol,2018,41(3):295-301.
[18] DONG L, HU S Y, ZHANG Q, et al. Dynamic changes of human papillomavirus genotype distribution in Shanxi cervical cancer screening cohort in 10 years[J]. Chin J Epidemiol,2017, 38(1):20-25.
[19] SUD A, THOMSEN H, SUNDQUIST K, et al. Risk of second cancer in hodgkin lymphoma survivors and influence of family history[J]. Clin Oncol,2017, 35(14):1584-1590.
[20] 刘苗苗,南岩东,陈艳丽,等.血清肿瘤标志物和自身抗体与肺癌患者临床病理特征的相关性研究[J]. 中华肺部疾病杂志,2018,11(2):176-181.

三重多原发恶性肿瘤病例分析

Analysis of triple multiple primary malignant neoplasms

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	符青云, 欧阳小明, 郅程, 曾亮. 基因芯片初步探讨乳腺癌转移相关蛋白Nucleobindin-2介导的信号通路[J]. 广州医药, 2022, 53(2): 56-67.
[2]	翁沛华. 超声-微泡介导miR-128通过调节PTEN抑制乳腺癌细胞阿霉素耐药[J]. 广州医药, 2021, 52(6): 35-38.
[3]	黎颂铭, 郝俊文, 洪云, 李良. 槐耳颗粒用于乳腺癌术后辅助化疗期对内分泌激素及生存期的影响[J]. 广州医药, 2021, 52(5): 109-112.
[4]	罗水妹, 黄颂平, 许白兰, 沈冰寒. 肺癌并发肺栓塞的危险因素及预后分析[J]. 广州医药, 2021, 52(2): 40-45.
[5]	孙策. ¹³¹I联合甘氨双唑钠治疗分化型甲状腺癌骨转移的临床疗效[J]. 广州医药, 2021, 52(2): 70-72.
[6]	叶晔, 费伟强, 冯冠. SEER数据库中晚期三阴性乳腺癌的危险因素及预后分析[J]. 广州医药, 2021, 52(1): 26-34.
[7]	李淑怡, 黄玉珍, 蓝秀万. 乳腺癌关键基因的生物信息学分析[J]. 广州医药, 2021, 52(1): 65-71.
[8]	聂力, 罗俊男, 温世锋. 手术与保守治疗无骨折脱位型颈脊髓损伤的Meta分析[J]. 广州医药, 2020, 51(4): 119-123.
[9]	郑守冰, 王松炎, 欧佳美. 肺癌患者化疗后细菌感染患者C反应蛋白、降钙素原、中性粒细胞及NLR水平研究[J]. 广州医药, 2020, 51(3): 57-60.
[10]	曾彬. 甲状腺癌患者健康知识认知详情和需求分析[J]. 广州医药, 2020, 51(3): 107-110.
[11]	黄毅敏, 向炳辉, 王小锋, 岑川, 邓永康. 乳腺癌根治术中保留乳头乳晕对术后疗效、上肢功能及外观满意度的影响[J]. 广州医药, 2020, 51(1): 121-124.
[12]	肖云华, 李宝秀. 重组人血管内皮抑素联合化疗治疗晚期非小细胞肺癌的效果[J]. 广州医药, 2019, 50(1): 72-75.
[13]	许素真. 阿那曲唑和他莫昔芬治疗激素受体阳性绝经后转移性乳腺癌的疗效和安全性对比[J]. 广州医药, 2018, 49(6): 118-120.
[14]	黄钻明, 谢汉清, 王开福, 张展庆. 肺结核与肺癌并存的CT影像研究[J]. 广州医药, 2018, 49(5): 86-88.
[15]	魏宜霖, 柳建华, 杨毓雯. 乳腺癌超声多参数及临床病理学特点与腋窝淋巴结转移的关系[J]. 广州医药, 2018, 49(5): 89-93.